ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.15%
US Dollar vs MXN
18.42315
-0.06%
Brent Oil
84.645
-0.06%
Bitcoin
65,659.06
1.06%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Avita Medical Inc (RCEL)

  7. Avita Medical Inc (RCEL) Noticias

RCEL Avita Medical Inc

8.02
0.00 (0.00%)
Pre Mercado
Última actualización: 03:31:14
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Avita Medical Inc RCEL NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 8.02 03:31:14
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.02
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/6/202419:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202418:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202415:39EDGAR2Form 8-K - Current report
05/6/202415:25GLOBEAVITA Medical Achieves Milestone with First Case Using..
03/6/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202415:28EDGAR2Form 8-K - Current report
30/5/202408:15GLOBEAVITA Medical Announces FDA Approval of RECELL GO
16/5/202417:30GLOBEAVITA Medical to Host Investor Webinar Briefing
13/5/202415:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202415:02EDGAR2Form 8-K - Current report
13/5/202415:01GLOBEAVITA Medical Reports First Quarter Financial Results
15/4/202416:05GLOBEAVITA Medical to Announce First Quarter 2024 Financial..
10/4/202416:11GLOBEAVITA Medical Updates Expected First Quarter 2024 Revenue
29/2/202415:02GLOBEAVITA Medical Submits Response to FDA, Resuming Review Clock..
29/2/202408:00GLOBEAVITA Medical to Present at TD Cowen 44th Annual Health Care..
23/2/202408:01GLOBEAVITA Medical to Host Investor Webinar Briefing
22/2/202415:02EDGAR2Form 8-K - Current report
22/2/202415:01GLOBEAVITA Medical Reports Fourth Quarter and Full-Year 2023..
01/2/202415:10GLOBEAVITA Medical to Announce Fourth Quarter and Full Year 2023..
10/1/202415:05EDGAR2Form 8-K - Current report
10/1/202415:01GLOBEAVITA Medical Announces Exclusive Distribution Agreement..
10/1/202408:01GLOBEAVITA Medical Announces Preliminary 2023 Financial..
05/1/202416:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202408:00GLOBEAVITA Medical to Present at the 42nd Annual J.P. Morgan..
04/12/202308:00GLOBEAVITA Medical to Host Investor Webinar Briefing
21/11/202315:15GLOBEAVITA Medical to Present at the Piper Sandler 35th Annual..
21/11/202308:10IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
20/11/202315:15GLOBEAVITA Medical Updates Full Year 2023 Guidance
09/11/202315:09EDGAR2Form 8-K - Current report
09/11/202315:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:01GLOBEAVITA Medical Reports Third Quarter Financial Results with..
09/11/202308:00GLOBEAVITA Medical Announces Distribution Partnership with..
23/10/202315:36EDGAR2Form 8-K - Current report
19/10/202315:05GLOBEAVITA Medical to Announce Third Quarter 2023 Financial..
18/10/202308:07EDGAR2Form 8-K - Current report
18/10/202308:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/10/202308:00GLOBEAVITA Medical Announces Preliminary Third Quarter 2023..
02/10/202307:56EDGAR2Form 8-K - Current report
25/9/202307:00GLOBEAVITA Medical Receives Best Product Award at the American..
21/9/202315:30GLOBEAVITA Medical to Present at the Cantor Global Healthcare..
08/9/202316:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202317:45GLOBEAVITA Medical to Participate in Upcoming Investor..
14/8/202307:00GLOBEAVITA Medical to Host Investor Webinar Briefing
10/8/202315:05EDGAR2Form 8-K - Current report
10/8/202315:01GLOBEAVITA Medical Reports Second Quarter Financial Results
20/7/202315:05GLOBEAVITA Medical to Announce Second Quarter 2023 Financial..
30/6/202315:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/6/202317:21GLOBEAVITA Medical Submits FDA PMA Supplement for RECELL GO
26/6/202307:00GLOBEAVITA Medical Rejoins the Russell 3000 Index

Su Consulta Reciente

NASDAQ
RCEL
Avita Medical
LSE
97GO
Coventry 8q%26
BIT
P1Z935
NLBNPIT1Z935 20240621 14
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados